Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) EPS (Weighted Average and Diluted) (2023 - 2025)

Volitionrx (VNRX) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$0.05 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) rose 28.57% year-over-year to -$0.05, compared with a TTM value of -$0.23 through Sep 2025, up 32.33%, and an annual FY2024 reading of -$0.31, up 38.0% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.05 for Q3 2025 at Volitionrx, up from -$0.06 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.05 in Q3 2025 and bottomed at -$0.12 in Q4 2023.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.08, with a median of -$0.06 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 50.86% in 2024, then grew 25.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.12 in 2023, then skyrocketed by 50.86% to -$0.06 in 2024, then increased by 16.67% to -$0.05 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for VNRX at -$0.05 in Q3 2025, -$0.06 in Q2 2025, and -$0.06 in Q1 2025.